Showing results (51-60 of 121) with videos related to
Sort By:
Pageof 13
Psychopharmacology Bulletin|January 1, 1991
Clinical factors that may confound the assessment of drug efficacyJ G Csernansky, J W Newcomer, L S Miller, et al.European Journal of Pharmacology|January 19, 1993
Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neurolepticsM E Bardgett, C T Wrona, J W Newcomer, et al.Behavioural Brain Research|October 1, 1995
Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophreniaM E Bardgett, J L Jackson, G T Taylor, et al.Psychiatry Research|November 1, 1989
CSF phenylacetic acid and hostility in paranoid schizophreniaK F Faull, R J King, J D Barchas, et al.The American Journal of Psychiatry|October 1, 1981
Fluphenazine decanoate and tardive dyskinesia: a possible associationJ G Csernansky, K Grabowski, J Cervantes, et al.The Journal of Nervous and Mental Disease|April 1, 1983
Detection of marijuana use in psychiatric patients by determination of urinary delta-9-tetrahydrocannabinol-11-oic acidJ R Magliozzi, S L Kanter, J G Csernansky, et al.Psychiatry Research|April 1, 1992
Fenfluramine stimulation of prolactin in obsessive-compulsive disorderW A Hewlett, S Vinogradov, K Martin, et al.Biological Psychiatry|August 15, 1996
Platelet serotonergic markers and Tridimensional Personality Questionnaire measures in a clinical sampleE C Nelson, C R Cloninger, T R Przybeck, et al.Psychiatry Research|June 11, 1991
Evaluating cognitive impairment in depression with the Luria-Nebraska Neuropsychological Battery: severity correlates and comparisons with nonpsychiatric controlsL S Miller, W O Faustman, J A Moses, et al.Behavioural Brain Research|March 1, 1997
Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801M E Bardgett, P S Jacobs, J L Jackson, et al.Pageof 13